Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
2024 WS
- Differentialdiagnose Innere Erkrankungen
- Klinische Chemie, Laboratoriumsdiagnostik (WA)
- Klinische Chemie, Laboratoriumsdiagnostik (PV)
- Hämatologisches und onkologisches Mittagsseminar
- Kurs der allgemeinen klinischen Untersuchungen (PV)
- Blockpraktikum Innere Medizin (PV)
- Innere Medizin für Studierende im Praktischen Jahr (*)
- E3 - Med - Cancer Biology - Cr. 3-3 - NEU
- Wahlfach: Cancer Biology
- Differentialdiagnose Innere Krankheiten
Vergangene Veranstaltungen (max. 10)
-
2024 SS
- Blockpraktikum Innere Medizin (PV)
- Klinische Chemie, Laboratoriumsdiagnostik (PV)
- Kurs der allgemeinen klinischen Untersuchungen (PV)
- Hämatologisches und onkologisches Mittagsseminar
- Klinische Chemie, Laboratoriumsdiagnostik (WA)
- Innere Medizin Vorlesung, Teil 1 (WA)
- Differentialdiagnose Innere Erkrankungen
- Wahlfach: Cancer Biology
- E3 - Med - Cancer Biology - Cr. 3-3
- Differentialdiagnose Innere Krankheiten
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantationIn: Bone Marrow Transplantation Jg. 59 (2024) Nr. 8, S. 1154 - 1160Online Volltext: dx.doi.org/ (Open Access)
-
Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients under 60 years of age : a prospective, phase II studyIn: Haematologica / The Hematology Journal Jg. 109 (2024) Nr. 5, S. 1469 - 1479Online Volltext: dx.doi.org/ (Open Access)
-
Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasisIn: JCI Insight Jg. 9 (2024) Nr. 10,Online Volltext: dx.doi.org/ (Open Access)
-
CDK9 inhibition as an effective therapy for small cell lung cancerIn: Cell Death and Disease Jg. 15 (2024) Nr. 5, 345Online Volltext: dx.doi.org/ (Open Access)
-
Correction to: ECP versus ruxolitinib in steroid-refractory chronic GVHD : A retrospective study by the EBMT transplant complications working partyIn: Bone Marrow Transplantation (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
Crizanlizumab in adult patients with sickle cell disease: : a retrospective German analysisIn: Frontiers in Hematology Jg. 3 (2024) 1374181Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survivalIn: Haematologica / The Hematology Journal Jg. 109 (2024) Nr. 1, S. 220 - 230Online Volltext: dx.doi.org/ (Open Access)
-
ECP versus ruxolitinib in steroid-refractory chronic GVHD : A retrospective study by the EBMT transplant complications working partyIn: Bone Marrow Transplantation Jg. 59 (2024) Nr. 3, S. 380 - 386Online Volltext: dx.doi.org/ (Open Access)
-
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNAIn: Blood Jg. 143 (2024) Nr. 6, S. 522 - 534Online Volltext: dx.doi.org/
-
Establishing Medical Intelligence - Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management : Retrospective Cohort and Clinical Implementation StudyIn: Journal of Medical Internet Research (JMIR) Jg. 26 (2024) e55148Online Volltext: dx.doi.org/ (Open Access)
-
How to optimize the CAR-T Cell therapy process? : A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspectiveIn: Frontiers in Oncology Jg. 14 (2024) 1466803Online Volltext: dx.doi.org/ (Open Access)
-
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2024) Nr. 5, S. 1361 - 1370Online Volltext: dx.doi.org/ (Open Access)
-
Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCRIn: European Journal of Haematology Jg. 112 (2024) Nr. 6, S. 957 - 963Online Volltext: dx.doi.org/ (Open Access)
-
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS : A study of the CMWP of the EBMTIn: American Journal of Hematology Jg. 99 (2024) Nr. 2, S. 203 - 215Online Volltext: dx.doi.org/ (Open Access)
-
Proteomic analysis of pleomorphic dermal sarcoma reveals a fibroblastic cell of origin and distinct immune evasion mechanismsIn: Scientific Reports Jg. 14 (2024) Nr. 1, 12516Online Volltext: dx.doi.org/ (Open Access)
-
Single-Center Experience of Patients with Plasma Cell Leukemia in the Era of New TherapeuticsIn: Acta Haematologica (2024) in pressOnline Volltext: dx.doi.org/
-
Single-cell analysis of a bi-clonal chronic lymphocytic leukemia reveals two clones with distinct gene expression patternIn: Leukemia and Lymphoma (2024) in pressOnline Volltext: dx.doi.org/ (Open Access)
-
XPO1-Mediated mRNA Export of Genome Maintenance Regulators Drives Chemotherapy Resistance in Aggressive LymphomaIn: Cancer Research Jg. 84 (2024) Nr. 1, S. 3 - 5Online Volltext: dx.doi.org/
-
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma : An international collaborative analysisIn: Leukemia Jg. 37 (2023) Nr. 7, S. 1511 - 1520Online Volltext: dx.doi.org/ (Open Access)
-
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanomaIn: Nature Cancer Jg. 4 (2023) Nr. 9, S. 1395Online Volltext: dx.doi.org/ (Open Access)
-
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4In: Haematologica / The Hematology Journal Jg. 108 (2023) Nr. 1, S. 34 - 41Online Volltext: dx.doi.org/ (Open Access)
-
Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosisIn: Journal of Neurology Jg. 270 (2023) Nr. 7, S. 3483 - 3491Online Volltext: dx.doi.org/ (Open Access)
-
Cost-effectiveness analysis of transplant-ineligible relapsed or refractory diffuse large B-cell lymphoma treatment options : Experience of the efficiency frontier approachIn: European Journal of Haematology Jg. 111 (2023) Nr. 6, S. 895 - 908Online Volltext: dx.doi.org/ (Open Access)
-
Data-driven grading of acute graft-versus-host diseaseIn: Nature Communications Jg. 14 (2023) Nr. 1, 7799Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Distinct genetically-determined origins of Myd88/Bcl2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategiesIn: Blood Cancer Discovery Jg. 4 (2023) Nr. 1, S. 78 - 97Online Volltext: dx.doi.org/ (Open Access)
-
Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9-induced leukaemic cellsIn: British Journal of Haematology Jg. 202 (2023) Nr. 5, S. 1033 - 1048Online Volltext: dx.doi.org/ (Open Access)
-
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission : a study from the Acute Leukemia Working Party of the EBMTIn: Bone Marrow Transplantation Jg. 58 (2023) Nr. 6, S. 710 - 716Online Volltext: dx.doi.org/ (Open Access)
-
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapyIn: Blood Jg. 142 (2023) Nr. 25, S. 2175 - 2191Online Volltext: dx.doi.org/ (Open Access)
-
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomasIn: Neuro-Oncology Jg. 25 (2023) Nr. 9, S. 1721 - 1723Online Volltext: dx.doi.org/ (Open Access)
-
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy : A real-world registry experienceIn: British Journal of Cancer (BJC) Jg. 129 (2023) Nr. 7, S. 1126 - 1133Online Volltext: dx.doi.org/ (Open Access)
-
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantationIn: Blood Jg. 141 (2023) Nr. 23, S. 2901 - 2911Online Volltext: dx.doi.org/ (Open Access)
-
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantationIn: Haematologica / The Hematology Journal Jg. 108 (2023) Nr. 2, S. 645 - 652Online Volltext: dx.doi.org/ (Open Access)
-
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit : Real-world data from the German SAL-AML registryIn: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 8, S. 4611 - 4621Online Volltext: dx.doi.org/ (Open Access)
-
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanomaIn: Nature Cancer Jg. 4 (2023) Nr. 9, S. 1292 - 1308Online Volltext: dx.doi.org/ (Open Access)
-
Intratumoral Abundance of M2-Macrophages is Associated With Unfavorable Prognosis and Markers of T-Cell Exhaustion in Small Cell Lung Cancer PatientsIn: Modern Pathology Jg. 36 (2023) Nr. 10, 100272Online Volltext: dx.doi.org/ (Open Access)
-
Mouse models of diffuse large B cell lymphomaIn: Frontiers in Immunology Jg. 14 (2023) 1313371Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell TherapyIn: HemaSphere: Open Access Journal of the European Hematology Association Jg. 7 (2023) Nr. 1, S. E817Online Volltext: dx.doi.org/ (Open Access)
-
Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donorsIn: The Journal of Clinical Investigation (JCI) Jg. 133 (2023) Nr. 12, e163548Online Volltext: dx.doi.org/ (Open Access)
-
Predicting HPV association using deep learning and regular H&E stains allows granular stratification of oropharyngeal cancer patientsIn: npj Digital Medicine Jg. 6 (2023) Nr. 1, 152Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prognostic factors for cellular therapies ‐ CART and allogeneic SCT ‐ in relapsed /refractory large B cell lymphoma (LBCL)In: Hematological Oncology Jg. 41 (2023) Nr. S2, 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023, S. 449 - 451Online Volltext: dx.doi.org/ (Open Access)
-
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancerIn: The Journal of Clinical Investigation (JCI) Jg. 133 (2023) Nr. 21, e174171Online Volltext: dx.doi.org/ (Open Access)
-
Time series clustering of T cell subsets dissects heterogeneity in immune reconstitution and clinical outcomes among MUD-HCT patients receiving ATG or PTCyIn: Frontiers in Immunology Jg. 14 (2023) 1082727Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell TransplantationIn: Clinical Cancer Research Jg. 28 (2022) Nr. 5, S. 1004 - 1012Online Volltext: dx.doi.org/ (Open Access)
-
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphomaIn: Blood Jg. 140 (2022) Nr. 10, S. 1119 - 1131Online Volltext: dx.doi.org/ (Open Access)
-
Acquired aplastic anemia following SARS-CoV-2 vaccinationIn: European Journal of Haematology Jg. 109 (2022) Nr. 2, S. 186 - 194Online Volltext: dx.doi.org/ (Open Access)
-
CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 HeterodimerizationIn: Molecular Cancer Therapeutics Jg. 21 (2022) Nr. 5, S. 821 - 830Online Volltext: dx.doi.org/ (Open Access)
-
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancerIn: Breast Cancer Research Jg. 24 (2022) Nr. 1, 41Online Volltext: dx.doi.org/ (Open Access)
-
Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosisIn: Annals of Clinical and Translational Neurology Jg. 9 (2022) Nr. 6, S. 853 - 863Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Correction to : Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaIn: Bone Marrow Transplantation Jg. 57 (2022) Nr. 12, 1854Online Volltext: dx.doi.org/ (Open Access)
-
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignanciesIn: Blood Jg. 140 (2022) Nr. 20, S. 2113 - 2126Online Volltext: dx.doi.org/ (Open Access)
-
Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variantIn: European Journal of Haematology Jg. 109 (2022) Nr. 4, S. 364 - 372Online Volltext: dx.doi.org/ (Open Access)
-
Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignanciesIn: Blood Jg. 139 (2022) Nr. 25, S. 3617 - 3629Online Volltext: dx.doi.org/ (Open Access)
-
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit from Higher Intensity Conditioning before Hematopoietic Cell Transplantation : An International Collaborative AnalysisIn: HemaSphere: Open Access Journal of the European Hematology Association Jg. 6 (2022) Nr. 10, E784Online Volltext: dx.doi.org/ (Open Access)
-
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaIn: Bone Marrow Transplantation Jg. 57 (2022) Nr. 7, S. 1116 - 1123Online Volltext: dx.doi.org/
-
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : A post-hoc analysis of the PETAL trialIn: Leukemia Jg. 36 (2022) Nr. 12, S. 2845 - 2852Online Volltext: dx.doi.org/ (Open Access)
-
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma : Interim analysis of the GMMG-CONCEPT trialIn: Leukemia Jg. 36 (2022) Nr. 3, S. 885 - 888Online Volltext: dx.doi.org/ (Open Access)
-
Luspatercept, a two‐edged sword in beta‐thalassemia‐associated paravertebral extramedullary hematopoietic masses (EHMs)In: European Journal of Haematology Jg. 109 (2022) Nr. 6, S. 664 - 671Online Volltext: dx.doi.org/ (Open Access)
-
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple MyelomaIn: Cancers Jg. 14 (2022) Nr. 8, 1955Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Preneoplastic somatic mutations including MYD88L²⁶⁵P in lymphoplasmacytic lymphomaIn: Science Advances Jg. 8 (2022) Nr. 3, eabl4644Online Volltext: dx.doi.org/ (Open Access)
-
Prevalence and predictors of neurological manifestations in systemic AL amyloidosisIn: Journal of the Neurological Sciences Jg. 440 (2022) 120341Online Volltext: dx.doi.org/
-
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosisIn: Blood Advances Jg. 6 (2022) Nr. 4, S. 1222 - 1231Online Volltext: dx.doi.org/ (Open Access)
-
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaIn: Blood Jg. 139 (2022) Nr. 4, S. 538 - 553Online Volltext: dx.doi.org/ (Open Access)
-
Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectivesIn: Scientific Reports Jg. 12 (2022) Nr. 1, 9762Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumorsIn: Journal for ImmunoTherapy of Cancer Jg. 10 (2022) Nr. 10, e004781Online Volltext: dx.doi.org/ (Open Access)
-
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1In: Blood Jg. 137 (2021) Nr. 5, S. 646 - 660Online Volltext: dx.doi.org/ (Open Access)
-
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomasIn: Blood Jg. 137 (2021) Nr. 20, S. 2785 - 2799Online Volltext: dx.doi.org/ (Open Access)
-
Altered DNA methylation profiles in SF3B1 mutated CLL patientsIn: International Journal of Molecular Sciences (IJMS) Jg. 22 (2021) Nr. 17, 9337Online Volltext: dx.doi.org/ (Open Access)
-
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular VulnerabilitiesIn: Cancer Discovery Jg. 2 (2021) Nr. 1, S. 70 - 91Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Biallelic variants in YRDC cause a developmental disorder with progeroid featuresIn: Human Genetics Jg. 140 (2021) Nr. 12, S. 1679 - 1693Online Volltext: dx.doi.org/ (Open Access)
-
Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E StainsIn: Clinical Cancer Research Jg. 27 (2021) Nr. 4, S. 1131 - 1138Online Volltext: dx.doi.org/ (Open Access)
-
Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapyIn: European Journal of Medical Research Jg. 26 (2021) Nr. 1, 63Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypesIn: Nature Communications Jg. 12 (2021) Nr. 1, S. 2048Online Volltext: dx.doi.org/ (Open Access)
-
Humoral and cellular vaccination responses against sars-cov-2 in hematopoietic stem cell transplant recipientsIn: Vaccines Jg. 9 (2021) Nr. 10, 1075Online Volltext: dx.doi.org/ (Open Access)
-
Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvementIn: European Journal of Haematology Jg. 107 (2021) Nr. 4, S. 449 - 457Online Volltext: dx.doi.org/ (Open Access)
-
Low Soluble Programmed Cell Death Protein 1 Levels After Allogeneic Stem Cell Transplantation Predict Moderate or Severe Chronic GvHD and Inferior Overall SurvivalIn: Frontiers in Immunology Jg. 12 (2021) 694843Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Pericentromeric Satellite III transcripts induce etoposide resistanceIn: Cell Death and Disease Jg. 12 (2021) Nr. 6, 530Online Volltext: dx.doi.org/ (Open Access)
-
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF) : A double-blind, randomised, placebo-controlled, phase 2b trialIn: The Lancet Respiratory Medicine Jg. 9 (2021) Nr. 5, S. 476 - 486Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Pregnancies and neonatal outcomes in patients with sickle cell disease (SCD) : Still a (high-)risk constellation?In: Journal of Personalized Medicine Jg. 11 (2021) Nr. 9, 870Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infectionsIn: Blood Advances Jg. 5 (2021) Nr. 5, S. 1259 - 1272Online Volltext: dx.doi.org/ (Open Access)
-
Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosisIn: Scientific Reports Jg. 11 (2021) Nr. 1, 22062Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Texture analysis of iodine maps and conventional images for k-nearest neighbor classification of benign and metastatic lung nodulesIn: Cancer Imaging Jg. 21 (2021) Nr. 1, S. 17Online Volltext: dx.doi.org/ (Open Access)
-
Thymic hyperplasia after mRNA based Covid-19 vaccinationIn: Radiology Case Reports Jg. 16 (2021) Nr. 12, S. 3744 - 3745Online Volltext: dx.doi.org/ (Open Access)
-
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysisIn: Bone Marrow Transplantation Jg. 56 (2021) S. 2160 - 2172Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Acute myeloid leukemia–induced remodeling of the human bone marrow niche predicts clinical outcomeIn: Blood Advances Jg. 4 (2020) Nr. 20, S. 5257 - 5268Online Volltext: dx.doi.org/ (Open Access)
-
Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to ImmunotherapyIn: Clinical Cancer Research Jg. 26 (2020) Nr. 21, S. 5638 - 5645Online Volltext: dx.doi.org/ (Open Access)
-
Meta-analysis reveals significant sex differences in chronic lymphocytic leukemia progression in the eµ-tcl1 transgenic mouse modelIn: Cancers Jg. 12 (2020) Nr. 7, S. 1980Online Volltext: dx.doi.org/ (Open Access)
-
Mutations in PIGA cause a CD52-/GPI-anchor-deficient phenotype complicating alemtuzumab treatment in T-cell prolymphocytic leukemiaIn: European Journal of Haematology Jg. 105 (2020) Nr. 6, S. 786 - 796Online Volltext: dx.doi.org/ (Open Access)
-
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerabilityIn: Nature Communications Jg. 11 (2020) Nr. 1, S. 4684Online Volltext: dx.doi.org/ (Open Access)
-
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53In: Theranostics Jg. 9 (2019) Nr. 21, S. 6047 - 6062Online Volltext: dx.doi.org/ (Open Access)
-
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive TumorsIn: Cell Jg. 176 (2019) Nr. 3, S. 505 - 519.e22Online Volltext: dx.doi.org/ (Open Access)
-
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemiaIn: Nature Communications Jg. 8 (2017) Nr. 1, S. 153Online Volltext: dx.doi.org/ (Open Access)
-
B-cell-specific conditional expression of Myd88p.L²⁵²P leads to the development of diffuse large B-cell lymphoma in miceIn: Blood Jg. 127 (2016) Nr. 22, S. 2732 - 2741Online Volltext: dx.doi.org/ (Open Access)
-
Ercc1 Deficiency Promotes Tumorigenesis and Increases Cisplatin Sensitivity in a Tp53 Context-Specific MannerIn: Molecular Cancer Research Jg. 14 (2016) Nr. 11, S. 1110 - 1123Online Volltext: dx.doi.org/
-
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerIn: Cell Jg. 162 (2015) Nr. 1, S. 146 - 159Online Volltext: dx.doi.org/ (Open Access)
-
Comprehensive genomic profiles of small cell lung cancerIn: Nature Jg. 524 (2015) Nr. 7563, S. 47 - 53Online Volltext: dx.doi.org/ (Open Access)
-
Erratum: A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant CancerIn: Cell Jg. 162 (2015) Nr. 5, S. 1169Online Volltext: dx.doi.org/ (Open Access)
-
Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemiaIn: Leukemia Jg. 29 (2015) Nr. 4, S. 981 - 984Online Volltext: dx.doi.org/
-
A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDCIn: Cancer Discovery Jg. 4 (2014) Nr. 5, S. 592 - 605Online Volltext: dx.doi.org/ (Open Access)
-
Therapeutic targeting of a robust non-oncogene addiction to PRKDC in ATM-defective tumorsIn: Science Translational Medicine Jg. 5 (2013) Nr. 189, S. 189ra78Online Volltext: dx.doi.org/
-
Cytokine-Induced Signaling Networks Prioritize Dynamic Range over Signal StrengthIn: Cell Jg. 135 (2008) Nr. 2, S. 343 - 354Online Volltext: dx.doi.org/ (Open Access)
-
14-3-3σ controls mitotic translation to facilitate cytokinesisIn: Nature Jg. 446 (2007) Nr. 7133, S. 329 - 332Online Volltext: dx.doi.org/
-
p53-Deficient Cells Rely on ATM- and ATR-Mediated Checkpoint Signaling through the p38MAPK/MK2 Pathway for Survival after DNA DamageIn: Cancer Cell Jg. 11 (2007) Nr. 2, S. 175 - 189Online Volltext: dx.doi.org/ (Open Access)
-
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal LymphomasIn: Cancer Discovery Jg. 13 (2023) Nr. 1, S. 216 - 243Online Volltext: dx.doi.org/
-
Editorial: Exploiting DNA Damage Response in the Era of Precision OncologyIn: Frontiers in Oncology Jg. 10 (2020) S. 611127Online Volltext: dx.doi.org/ (Open Access)
-
Association of Cardiac Biomarkers and Adverse Events with a Carfilzomib-Containing Quadruplet in High-Risk Newly Diagnosed Multiple Myeloma Patients: Correlative Program of the GMMG-CONCEPT TrialIn: Clinical Lymphoma, Myeloma & Leukemia Jg. 24 (2024) Nr. Suppl. 2, S. S12 - S13Online Volltext: dx.doi.org/
-
Isa-KRd in High-Risk Newly Diagnosed Multiple Myeloma : 4-Year-Follow-Up from the GMMG-CONCEPT trialIn: Clinical Lymphoma, Myeloma & Leukemia Jg. 24 (2024) Nr. Suppl. 2, S. S33 - S34Online Volltext: dx.doi.org/
-
ATG/ATLG Improves GvHD-Free and Relapse-Free Survival in Myelofibrosis Undergoing Hematopoietic Stem Cell TransplantationIn: Blood Jg. 142 (2023) Nr. Supplement 1: Annual Meeting Abstracts (65th ASH Annual Meeting and Exposition, 9-12 Dezember 2023, San Diego), S. 3572 - 3572Online Volltext: dx.doi.org/ (Open Access)
-
Allogeneic hematopoietic stem cell transplantation achieves long-term survival in Natural killer/T-cell lymphoma in the era of Asparaginase-based Chemotherapy
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 104 - 105Online Volltext: dx.doi.org/ (Open Access) -
An In Vivo PiggyBac Insertional Mutagenesis Screen Reveals Oncogenic Lesions Cooperating with Myd88 L265P
65th ASH Annual Meeting, December 9-12, 2023, San Diego, CA, USA,In: Blood Jg. 142 (2023) Nr. Supplement 1, S. 525 - 526Online Volltext: dx.doi.org/ (Open Access) -
Investigation of cardiac biomarkers and association with clinical course under treatment with a carfilzomib containing quadruplet regimen in high-risk newly diagnosed multiple myeloma patients : results from the correlative program of the GMMG-CONCEPT trial
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 32 - 33Online Volltext: dx.doi.org/ (Open Access) -
Planned Interim Analysis of the GMMG-CONCEPT Trial investigating Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 55 - 56Online Volltext: dx.doi.org/ (Open Access) -
Allogeneic Hematopoietic Stem Cell Transplantation Achieves Long-Term Survival in Extranodal Natural Killer/T-Cell Lymphoma : A Retrospective Analysis of the EBMT Lymphoma Working Party
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 2306 - 2307Online Volltext: dx.doi.org/ (Open Access) -
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancerIn: Geburtshilfe und Frauenheilkunde Jg. 82 (2022) Nr. 10, S. e146Online Volltext: dx.doi.org/
-
Glomerular Fitration Rate and Lactate Dehydrogenase Predicts Survival in Mayo Iiib Stage Light-Chain AmyloidosisIn: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 12571 - 12572Online Volltext: dx.doi.org/ (Open Access)
-
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma : Planned Interim Analysis of the GMMG-Concept Trial
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,In: Blood Jg. 140 (2022) Nr. Supplement 1, S. 1836 - 1838Online Volltext: dx.doi.org/ (Open Access) -
Luspatercept bei Patienten mit transfusionsabhängiger β-Thalassämie : die erste reale Analyse
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 49Online Volltext: dx.doi.org/ (Open Access) -
Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-SequencingIn: Blood Jg. 140 (2022) Nr. Suppl. 1, S. 3537 - 3538Online Volltext: dx.doi.org/ (Open Access)
-
Novel Autochthonous Mouse Models of Serve As Preclinical Tools to Investigate Pathogenesis and Treatment of MCD/C5 DLBCL
64th ASH Annual Meeting and Exposition, 10-13 December 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th ASH Annual Meeting Abstracts, S. 3493 - 3494Online Volltext: dx.doi.org/ (Open Access) -
Phänotyp von TP53 und Einfluss auf Outcome nach allogener Stammzelltransplantation bei Myelofibros
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 80Online Volltext: dx.doi.org/ (Open Access) -
Stem cell boost for persistent cytopenia after chimeric antigen receptor t-cell therapy : A German Lymphoma alliance (GLA) studyIn: Bone Marrow Transplantation Jg. 57 (2022) Nr. Suppl. 1, S. 30 - 31
-
Venetoclax and Hypomethylating Agents Followed by Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 12943 - 12944Online Volltext: dx.doi.org/ (Open Access) -
Voxelotor bei Jugendlichen und Erwachsenen mit Sichelzellkrankheit : erste Erfahrungen aus dem deutschen Härtefallprogramm
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 48Online Volltext: dx.doi.org/ (Open Access) -
An autochthonous mouse model provides a rational for combined BTK and BCL2 inhibition in MYD88-mutant diffuse large B cell lymphoma
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 127Online Volltext: dx.doi.org/ (Open Access) -
Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 1307 - 1310Online Volltext: dx.doi.org/ (Open Access) -
Comparative Analysis of Immune Reconstitution In HSCT Patients With PT-CY OR ATG Reveals Distinct T Cell Immune Reconstitution PatternsIn: Bone Marrow Transplantation Jg. 56 (2021) Nr. Suppl. 1, S. 126
-
Retrospective Analysis Evaluating The Effect of Age on Outcomes After Allogeneic Hematopoietic Cell Transplantation In Chronic Myelomonocytic Leukemia : A Study of The EBMT-CMWPIn: Bone Marrow Transplantation Jg. 56 (2021) Nr. Suppl. 1, S. 139 - 141
-
Trends and Predictive Factors for Outcome of Relapsed Philadelphia Positive Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Cell Transplantion : Improvement of Survival in Recent YearsIn: Bone Marrow Transplantation Jg. 56 (2021) Nr. Suppl. 1, S. 23 - 24
-
Updated interim analysis of the GMMG-CONCEPT trial investigating Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in front-line treatment of high-risk Multiple Myeloma
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 20 - 21Online Volltext: dx.doi.org/ (Open Access) -
Think twice : Anemia of chronic disease (ACD) due to angiomatoid fibrous histiocytoma (AFH)
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 181Online Volltext: dx.doi.org/ (Open Access) -
Intraspinal extramedullary hematopoietic mass (EMH) in a luspatercept-treated patient with transfusion-dependent beta-thalassemia (TDT)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DHGO Abstracts, S. 299 - 300Online Volltext: dx.doi.org/ (Open Access) -
New Suitable Eµ-Tcl1 Mouse Model for Research on BH3-Mimetics Therapy Response In Vivo
65th ASH Annual Meeting, December 9-12, 2023, San Diego, CA, USA,In: Blood Jg. 142 (2023) Nr. Supplement 1, S. 1454 - 1454Online Volltext: dx.doi.org/ (Open Access) -
Predicting HPV-association using regular H&E slides can identify subgroups of patients with favorable prognosis at a highly detailed level
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S561Online Volltext: dx.doi.org/ (Open Access) -
Real-world experience with hypomethylating agents and venetoclax as induction or salvage therapy followed by allogeneic stem cell transplantation in patients with acute myeloid leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 193Online Volltext: dx.doi.org/ (Open Access) -
Allele-specific single-nucleotide polymorphisms for NGS-based detection of HLA loss relapses after hematopoietic cell transplantation
Joint 35th European Immunogenetics and Histocompatibility Conference; May 17–20, 2022; Amsterdam, the Netherlands,In: HLA: Immune Response Genetics (Human Leukocyte Antigens) Jg. 99 (2022) Nr. 5, SI, S. 487 -
CART Therapy or Allogeneic Stem Cell Transplantation in ≥ Third Line Treatment of Large B Cell Lymphoma (LBCL)
64th Annual Meeting and Exposition of the American Society of Hematology, December 10 - 13, 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 7509 - 7511Online Volltext: dx.doi.org/ (Open Access) -
Venetoclax-Based Salvage Therapy Improves Outcome in Relapsed/Refractory AML Patients Eligible for Intensive Treatment : A Propensity Score Matching Analysis
64th Annual Meeting and Exposition of the American Society of Hematology, December 10 - 13, 2022, New Orleans,In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 3317 - 3319Online Volltext: dx.doi.org/ (Open Access) -
Low soluble programmed cell death protein 1 levels post allogeneic stem cell transplantation predict extended chronic graft-versus-host disease and inferior overall survival
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 233Online Volltext: dx.doi.org/ (Open Access) -
RICarT : Registry for immune-effector and CAR T associated toxicities
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 258Online Volltext: dx.doi.org/ (Open Access)